Filing Details

Accession Number:
0001140361-10-030843
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-07-30 13:00:00
Reporting Period:
2010-07-28
Filing Date:
2010-07-30
Accepted Time:
2010-07-30 13:56:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS Pharmaceutical Preparations (2834) 141902018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1380187 Daniel Abdun-Nabi 2273 Research Blvd. Suite 400
Rockville MD 20850
President & Coo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-07-28 7,950 $18.92 34,345 No 4 S Direct
Common Stock Disposition 2010-07-29 10,200 $18.65 24,145 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi. Mr. Abdun-nabi's direct holdings include restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan that vest in three equal installments beginning March 9, 2011.